SOCIBP: Swiss Molecular Pathology Breakthrough Platform by Mark Rubin (University Bern)

 

Speaker: Prof Mark Rubin
Director, Department for BioMedical Research, University of Bern and Bern Center for Precision Medicine Inselspital, University Hospital

Despite the rapid proliferation of novel therapies for cancer, tumor cell resistance remains one of the greatest unmet challenges in oncology. Molecular pathology approaches have raised awareness of novel mechanisms for drug resistance. Our SOCIBP project (Swiss Oncology and Cancer Immunology Breakthrough Platform for Precision Oncology) will address this problem head-on. Read the abstract...

Scroll to Top